Skip to main content
Year archive

H. Lundbeck A — 2022 filings

All 27 regulatory filings released by H. Lundbeck A (HLUN) in 2022, sourced directly from the official regulator.

27 Filings
2022 Period
2022 filings (27)
Filing Released Lang
Earnings Release 2022
Earnings Release FY 2022
2022-11-08 English
Lundbeck raises financial guidance range for the full year 2022
Earnings Release FY 2022
2022-11-08 Danish
Interim / Quarterly Report 2022
Interim / Quarterly Report H1 2022
2022-08-17 English
Lundbeck’s sales increased by +7% (+3% in local currencies) to DKK 8,847 million in the first half of 2022
Earnings Release H1 2022
2022-08-17 Danish
Earnings Release 2022
Earnings Release FY 2022
2022-08-09 English
Lundbeck raises financial guidance range for the full year 2022
Earnings Release FY 2022
2022-08-09 Danish
Director's Dealing 2022
Director's Dealing
2022-07-12 English
Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties
Director's Dealing
2022-07-12 Danish
Earnings Release 2022
Earnings Release Q2 2022
2022-06-27 English
Lundbeck and Otsuka Pharmaceutical announce positive results showing reduced agitation in patients with Alzheimer’s dementia treated with brexpiprazole
Regulatory Filings
2022-06-27 English
New share structure and official listing of new share classes, and total number of voting rights and share capital
Share Issue/Capital Change
2022-06-08 English
New share structure and official listing of new share classes, and total number of voting rights and share capital
Share Issue/Capital Change
2022-06-08 English
Approval of prospectus for H. LUNDBECK A/S; Share certificates
Share Issue/Capital Change
2022-05-20 English
Share Issue/Capital Change 2022
Share Issue/Capital Change
2022-05-20 English
Lundbeck publishes Listing Document relating to the new share structure
Report Publication Announcement
2022-05-20 English
Annual Report (ESEF) 2021
Annual Report (ESEF) FY 2021
2022-02-25 English
Regulatory Filings 2022
Regulatory Filings
2022-02-25 English
Lundbeck Annual Report 2021
Regulatory Filings
2022-02-25 English
Report Publication Announcement 2022
Report Publication Announcement
2022-02-09 English
Annual Report (ESEF) 2021
Annual Report (ESEF) FY 2021
2022-02-09 English
Lundbeck Annual Report 2021
Regulatory Filings
2022-02-09 Danish
Earnings Release 2021
Earnings Release FY 2021
2022-02-09 English
Strong operational performance with continued solid growth from strategic brands in Q4 2021
Regulatory Filings
2022-02-09 Danish
Share Issue/Capital Change 2022
Share Issue/Capital Change
2022-02-09 English
Lundbeck proposes a new share structure with A-shares and B-shares to increase financial capacity to fund future growth opportunities
Share Issue/Capital Change
2022-02-09 English
Regulatory Filings 2022
Regulatory Filings
2022-01-24 English
Vyepti[®] (eptinezumab) approved by the EU Commission for the preventive treatment of migraine in adults
Regulatory Filings
2022-01-24 English